'Formulations' diaporamas de présentation

Lectures 14-15: Deontological & Consequential Ethics

Lectures 14-15: Deontological & Consequential Ethics. Consider these quotes:.

1.75k views • 106 slides

Merck Overview Merck Research Laboratories Partnerships and Licensing Policy and other

893 views • 34 slides

CHM 585/490

CHM 585/490. Chapter 20. Soaps and Bulging Drum Case Story. Soaps. Contain both a hydrophilic (water loving) end and a hydrophobic (water repelling) portion. Hydrophilic end is the carboxylate salt Hydrophobic end is the aliphatic end U.S. soap & detergent industry about $10 billion.

453 views • 32 slides

Chapter 7

Chapter 7. Routes and Formulations. Routes and Formulations. The way the body absorbs and distributes drugs varies with the route of administration. Drugs are contained in formulations and the route of administration is either enteral or parenteral .

425 views • 30 slides

Attractive Mathematical Representations Of Decision Problems

Attractive Mathematical Representations Of Decision Problems. Warren Adams 11/04/03. Research Interests. Design and implementation of solution strategies for difficult (nonconvex) decision problems. Theoretical development. Algorithmic design. Computer implementation.

399 views • 26 slides

Access to Paediatric ARV Formulations The plight of Children

362 views • 22 slides

Overview of Presentation

262 views • 20 slides

On a cognitive search strategy

308 views • 20 slides

Lecture 1 Formulation of Drugs into Parenteral Preparations

Lecture 1 Formulation of Drugs into Parenteral Preparations. By Prof. Dr. Kadria A. Elkhodairy. Consideration to be taken in parenteral preparation. Solvents or vehicles must meet special purity & other standard to assure their safety by injection.

1.27k views • 19 slides

Corporate Presentation

357 views • 19 slides

Where do current agro trends come from and what is the future trends

429 views • 18 slides

Lupin Press Meet

Lupin Press Meet. October 7, 2003. Background and Origin. Current Operations and Strengths. Recent Business Successes. Strategy for the Future. The Building Blocks. Glimpse into the Future. Background and Origin. Background and Origin.

296 views • 17 slides

Bioequivalence of Topical Products

Bioequivalence of Topical Products. OGD Research Program Lawrence Yu,Ph.D. Dermatopharmacokinetics Annette Bunge, Ph.D. Bioequivalence of Topical Products Jonathan Wilkin, M.D. Q& A . Q1: Qualitative Similarity Same components Q2: Quantitative Similarity

235 views • 15 slides

Numerical Astrophysics at FAUST

Numerical Astrophysics at FAUST. Pedro Marronetti Florida Atlantic University November 4, 2004. Work (to be) done in collaboration with Christopher Beetle Steve Bruenn Warner Miller Wolfgang Tichy. The Roads Ahead. Main Objectives

394 views • 14 slides

Nandita Sugandhi, M.D. Clinton Health Access Initiative July 22, 2014 Melbourne, Australia

The Role of the IATT Optimal Paediatric ARV Formulary and Considerations for New Product Introduction. Nandita Sugandhi, M.D. Clinton Health Access Initiative July 22, 2014 Melbourne, Australia. Overview. The Pediatric ARV Market is small and relatively complex

357 views • 14 slides

GAVI R&D Task Force August 2001

Technologies in Support of Immunization Programs. GAVI R&D Task Force August 2001. GAVI R&D Task Force.

257 views • 13 slides

Patient needs driven Research and Development Agenda in HIV

Patient needs driven Research and Development Agenda in HIV. Dr. Felipe Garcia de la Vega MSF Campaign for Access to Essential Medicines. HIV in Mozambique. Mozambique is one of the poorest countries in the world. Today 1.3 m people live with HIV in Mozambique. 99,000 children

233 views • 13 slides

Current issues and challenges in the development of IP monographs

Current issues and challenges in the development of IP monographs. Dr. G.N. Singh Secretary-cum-Scientific Director Indian Pharmacopoeia Commission Ghaziabad.

279 views • 13 slides

Blau R: 0 G: 88 B: 156

Blau R: 0 G: 88 B: 156. Feuerrot - Health R: 212 G: 45 B: 18. Hellblau R: 102 G: 153 B: 255. Orange - Struktur R: 207 G: 104 B: 0. Grau 1 R: 81 G: 81 B: 81. Gelb - Energie R: 230 G: 175 B: 17.

169 views • 6 slides

European Injectable Drug Delivery Market by Therapeutic & Type - 2020

European Injectable Drug Delivery Market report categorizes the europe market by Therapeutic (Oncology, Hormonal), Type (Formulation, Device), Administration (Musculoskeletal, Skin), Usage Pattern (Immunization, Curative Care), End User (Hospital, Home care Setting) & Geography.

72 views • 6 slides